Grace Kung, MD, FACC, FASE
Dr. Kung graduated from the Johns Hopkins University with a Bachelors of Arts in Biology in 1989 and attended The Johns Hopkins School of Medicine, graduating in 1993. She completed her pediatric internship and residency and pediatric cardiology fellowship at the University of California at San Francisco from 1993-1999. Dr. Kung was then an Assistant Professor of Pediatrics at Texas Children’s Hospital in Houston from 1999-2003 and joined the faculty at USC/Children's Hospital Los Angeles in 2003. She has been board certified in pediatric cardiology since 2001. She has been Fellowship Program Director since 2014 and has been on the Promotions Committee since 2019. She has also taken a lead in the CHLA junior faculty mentoring program.
Clinical care and evaluation of children with congenital heart disease in the outpatient, inpatient and peri-operative setting; non-invasive imaging including transthoracic and transesophageal imaging.
Dr. Kung has actively participated in the National Pediatric Cardioloy QI Collaborative since 2009 to improve outcomes for single ventricle patients with HLHS.
Education
Johns Hopkins School of Medicine
University of California at San Francisco: Pediatrics
University of California at San Francisco: Pediatrics
University of California San Francisco: Pediatric Cardiology
Accomplishments
Pediatric Cardiology: American Board of Pediatrics
Fellow, American College of Cardiology; Fellow, American Society of Echocardiography; Member, Western Society of Pediatric Cardiology.
Wyeth Ayerst 'Women in Cardiology' award, American Heart Association, 71st Scientific Session, Dallas, 1998
Publications
Portman MA, Slee A, Olson AK, Cohen G, Karl T, Tong E, Hastings L, Patel H, Reinhartz O, Mott AR, Mainwaring R, Linam J, Danzi S; (Kung G, member of TRICC Investigators). Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis. Circulation. 122 (11 Suppl):S224-33, 2010 Sep 14. PMID: 20837917
Feltes TF, Sondheimer HM, Tulloh RM, Harris BS, Jensen KM, Losonsky GA, Griffin MP; Motavizumab Cardiac Study Group. A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease. Pediatr Res. 2011 Aug;70(2):186-91. PMID: 21522037
(Member of the Motavizumab Cardiac Study Group).
Castellanos DA*, Herrington C, Adler S, Haas K, Ram Kumar S, Kung GC**. Home Monitoring Program Reduces Mortality in High-Risk Sociodemographic Single-Ventricle Patients. Pediatr Cardiol. 2016 Dec;37(8):1575-1580.PMID: 27554255
Kumar SR, Kung G, Noh N, Castillo N, Fagan B, Wells WJ, Starnes VA. Single-Ventricle Outcomes After Neonatal Palliation of Severe Ebstein Anomaly With Modified Starnes Procedure. Circulation.1257-1264, 2016 Oct 25. PMID: 27777295
Karamlou T, Peyvandi S, Federman M, Goff D, Murthy R, Kumar SR; Southwest Congenital Cardiac Consortium. Resolving the Fontan paradox: Addressing socioeconomic and racial disparities in patients with a single ventricle. J Thorac Cardiovasc Surg. 2018 Apr;155(4):1727-1731. PMID: 29395194
(Member of the Consortium)
6. Su JA*, Kumar SR, Mahmoud H, Bowdish ME, Toubat O, Wood JC, Kung GC. Postoperative Serum Troponin Trends in Infants Undergoing Cardiac Surgery. Semin Thorac Cardiovasc Surg. 2018 Sep 5 . pii: S1043-0679(18)30208-9. doi: 10.1053/j.semtcvs.2018.08.010. [Epub ahead of print] PMID: 30194978
